Literature DB >> 23407226

Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

H E Jenkins1, A Ciobanu, V Plesca, V Crudu, I Galusca, V Soltan, T Cohen.   

Abstract

SETTING: The Republic of Moldova, in Eastern Europe, has among the highest reported nationwide proportions of tuberculosis (TB) patients with multidrug-resistant tuberculosis (MDR-TB) worldwide. Default has been associated with increased mortality and amplification of drug resistance, and may contribute to the high MDR-TB rates in Moldova.
OBJECTIVE: To assess risk factors and timing of default from treatment for non-MDR-TB from 2007 to 2010.
DESIGN: A retrospective analysis of routine surveillance data on all non-MDR-TB patients reported.
RESULTS: A total of 14.7% of non-MDR-TB patients defaulted from treatment during the study period. Independent risk factors for default included sociodemographic factors, such as homelessness, living alone, less formal education and spending substantial time outside Moldova in the year prior to diagnosis; and health-related factors such as human immunodeficiency virus co-infection, greater lung pathology and increasing TB drug resistance. Anti-tuberculosis treatment is usually initiated within an institutional setting in Moldova, and the default risk was highest in the month following the phase of hospitalized treatment (among civilians) and after leaving prison (among those diagnosed while incarcerated).
CONCLUSIONS: Targeted interventions to increase treatment adherence for patients at highest risk of default, and improving the continuity of care for patients transitioning from institutional to community care may substantially reduce risk of default.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23407226      PMCID: PMC3710709          DOI: 10.5588/ijtld.12.0464

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  19 in total

1.  Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.

Authors:  S S Shin; A D Pasechnikov; I Y Gelmanova; G G Peremitin; A K Strelis; S Mishustin; A Barnashov; Y Karpeichik; Y G Andreev; V T Golubchikova; T P Tonkel; G V Yanova; M Nikiforov; A Yedilbayev; J S Mukherjee; J J Furin; D J Barry; P E Farmer; M L Rich; S Keshavjee
Journal:  Int J Tuberc Lung Dis       Date:  2006-04       Impact factor: 2.373

2.  Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.

Authors:  W M Jakubowiak; E M Bogorodskaya; S E Borisov; E S Borisov; I D Danilova; D I Danilova; E V Kourbatova; E K Kourbatova
Journal:  Int J Tuberc Lung Dis       Date:  2007-01       Impact factor: 2.373

3.  Increasing tuberculosis case detection: lessons from the Republic of Moldova.

Authors:  Viorel Soltan; Asma Khalid Henry; Valeriu Crudu; Irina Zatusevski
Journal:  Bull World Health Organ       Date:  2008-01       Impact factor: 9.408

4.  Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi.

Authors:  T E Nyirenda; A D Harries; F Gausi; J van Gorkom; D Maher; K Floyd; F M L Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2003-09       Impact factor: 2.373

5.  Mortality of tuberculosis patients in Chennai, India.

Authors:  C Kolappan; R Subramani; K Karunakaran; P R Narayanan
Journal:  Bull World Health Organ       Date:  2006-07       Impact factor: 9.408

6.  Movement of tuberculosis patients and the failure to complete antituberculosis treatment.

Authors:  K C Cummings; J Mohle-Boetani; S E Royce; D P Chin
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

7.  Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis.

Authors:  Suzanne Verver; Robin M Warren; Nulda Beyers; Madalene Richardson; Gian D van der Spuy; Martien W Borgdorff; Donald A Enarson; Marcel A Behr; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2005-04-14       Impact factor: 21.405

8.  Nonadherence in tuberculosis treatment: predictors and consequences in New York City.

Authors:  A Pablos-Méndez; C A Knirsch; R G Barr; B H Lerner; T R Frieden
Journal:  Am J Med       Date:  1997-02       Impact factor: 4.965

9.  Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance.

Authors:  I Y Gelmanova; S Keshavjee; V T Golubchikova; V I Berezina; A K Strelis; G V Yanova; S Atwood; M Murray
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

10.  Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.

Authors:  Helen E Jenkins; Valeriu Plesca; Anisoara Ciobanu; Valeriu Crudu; Irina Galusca; Viorel Soltan; Aliona Serbulenco; Matteo Zignol; Andrei Dadu; Masoud Dara; Ted Cohen
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671

View more
  10 in total

1.  High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova.

Authors:  Helen E Jenkins; Valeriu Crudu; Viorel Soltan; Ana Ciobanu; Liliana Domente; Ted Cohen
Journal:  Eur Respir J       Date:  2014-02-20       Impact factor: 16.671

2.  Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study.

Authors:  Jessica Wohlleben; Mavluda Makhmudova; Firuza Saidova; Shahnoza Azamova; Christina Mergenthaler; Suzanne Verver
Journal:  BMC Infect Dis       Date:  2017-08-04       Impact factor: 3.090

3.  Evaluating the impact of social support services on tuberculosis treatment default in Ukraine.

Authors:  Martha Priedeman Skiles; Siân L Curtis; Gustavo Angeles; Stephanie Mullen; Tatyana Senik
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

4.  Patients' perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study.

Authors:  Omowunmi Aibana; Emily Dauria; Tetiana Kiriazova; Olena Makarenko; Mariya Bachmaha; Natasha Rybak; Timothy Palen Flanigan; Vasyl Petrenko; Anne E Becker; Megan B Murray
Journal:  BMJ Open       Date:  2020-02-02       Impact factor: 2.692

5.  A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.

Authors:  Kurt Wollenberg; Michael Harris; Andrei Gabrielian; Nelly Ciobanu; Dumitru Chesov; Alyssa Long; Jessica Taaffe; Darrell Hurt; Alex Rosenthal; Michael Tartakovsky; Valeriu Crudu
Journal:  BMC Infect Dis       Date:  2020-01-07       Impact factor: 3.090

6.  The impact of the stratification by degree of clinical severity and abandonment risk of tuberculosis treatment.

Authors:  Pedro Daibert de Navarro; João Paulo Amaral Haddad; Juliana Veiga Costa Rabelo; Claudia Hermínia de Lima E Silva; Isabela Neves de Almeida; Wânia da Silva Carvalho; Silvana Spíndola de Miranda
Journal:  J Bras Pneumol       Date:  2021-09-06       Impact factor: 2.624

7.  Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.

Authors:  Olanrewaju Oladimeji; Petros Isaakidis; Olusegun J Obasanya; Osman Eltayeb; Mohammed Khogali; Rafael Van den Bergh; Ajay M V Kumar; Sven Gudmund Hinderaker; Saddiq T Abdurrahman; Lovett Lawson; Luis E Cuevas
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

8.  Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study.

Authors:  Emily A Kendall; Danie Theron; Molly F Franke; Paul van Helden; Thomas C Victor; Megan B Murray; Robin M Warren; Karen R Jacobson
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

9.  Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Authors:  Shona Horter; Beverley Stringer; Jane Greig; Akhmet Amangeldiev; Mirzagaleb N Tillashaikhov; Nargiza Parpieva; Zinaida Tigay; Philipp du Cros
Journal:  BMC Infect Dis       Date:  2016-07-28       Impact factor: 3.090

10.  Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.

Authors:  Maja Stosic; Dejana Vukovic; Dragan Babic; Gordana Antonijevic; Kristie L Foley; Isidora Vujcic; Sandra Sipetic Grujicic
Journal:  BMC Public Health       Date:  2018-09-12       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.